NEW YORK, July 14 - In testimony before the Joint Economic Committee of the US Congress last week, FDA Commissioner Mark McClellan warned that innovative biomedical technologies such as genomics, proteomics, and bioinformatics may lead to an increase in the overall costs of healthcare, but noted that "the potential benefits of new treatments could grow even more dramatically."

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.